FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057360087> ?p ?o ?g. }

• W2057360087 endingPage "108" @default.
• W2057360087 startingPage "101" @default.
• W2057360087 abstract "High-dose chemotherapy combined with autologous stem cell support has improved response rates in high-risk and metastatic breast cancer, but has failed to improve long-term survival. Breast cancer has a tendency to metastasize to the bone marrow, and live tumor cells are known to circulate in the peripheral blood of breast cancer patients. Sensitive immunohistochemical, culture-based, and reverse transcriptase polymerase chain reaction (RT-PCR)-based methods have shown that about 50% of histologically normal stem cell grafts from breast cancer patients are contaminated with occult tumor cells, which may cause or contribute to tumor recurrences. Merocyanine 540 (MC540)-mediated photodynamic therapy (PDT) inactivates a wide range of leukemia and lymphoma cells and is well tolerated by normal hematopoietic stem and progenitor cells. Unfortunately, most solid tumor cells (including breast cancer cells) are only moderately sensitive or refractory to MC540-PDT. We report here that if MC540-PDT is followed by a 1-h incubation with the alkyl-lysophospholipid, Edelfosine (ET-18-OCH(3)), the depletion of murine and human breast cancer cells is greatly enhanced whereas the recovery of normal hematopoietic stem and progenitor cells is only minimally degraded. When used under conditions that reduce CD34-positive human bone marrow cells only 5.1-fold, and murine and human granulocyte/macrophage progenitors 6.8- and 3-fold, respectively, combination purging with MC540-PDT and Edelfosine depletes murine (Mm5MT) and human (MDA-MB-435S) breast cancer cells >17,000- and >125,000-fold, respectively. These data suggest that combination purging with MC540-PDT and Edelfosine may offer a simple, safe and effective method for the ex vivo purging of autologous stem cell grafts from breast cancer patients." @default.
• W2057360087 created "2016-06-24" @default.
• W2057360087 creator A5002556868 @default.
• W2057360087 creator A5030969362 @default.
• W2057360087 creator A5032646223 @default.
• W2057360087 creator A5078086617 @default.
• W2057360087 date "2002-11-01" @default.
• W2057360087 modified "2023-09-25" @default.
• W2057360087 title "Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients" @default.
• W2057360087 cites W1931317611 @default.
• W2057360087 cites W1982583218 @default.
• W2057360087 cites W1989986931 @default.
• W2057360087 cites W1991856489 @default.
• W2057360087 cites W1995541277 @default.
• W2057360087 cites W2020855915 @default.
• W2057360087 cites W2029754737 @default.
• W2057360087 cites W2049842763 @default.
• W2057360087 cites W2052343019 @default.
• W2057360087 cites W2062644575 @default.
• W2057360087 cites W2063592572 @default.
• W2057360087 cites W2068503437 @default.
• W2057360087 cites W2072856162 @default.
• W2057360087 cites W2078697756 @default.
• W2057360087 cites W2083878344 @default.
• W2057360087 cites W2094387944 @default.
• W2057360087 cites W2099070927 @default.
• W2057360087 cites W2115368218 @default.
• W2057360087 cites W2120581565 @default.
• W2057360087 cites W2132984129 @default.
• W2057360087 cites W2137687304 @default.
• W2057360087 cites W2154037033 @default.
• W2057360087 cites W2172876112 @default.
• W2057360087 cites W2249401906 @default.
• W2057360087 cites W231841565 @default.
• W2057360087 cites W2323031981 @default.
• W2057360087 cites W2327080978 @default.
• W2057360087 cites W2327522594 @default.
• W2057360087 cites W2342082762 @default.
• W2057360087 cites W2393873239 @default.
• W2057360087 cites W299617768 @default.
• W2057360087 cites W4230561477 @default.
• W2057360087 doi "https://doi.org/10.1016/s1011-1344(02)00377-9" @default.
• W2057360087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12468204" @default.
• W2057360087 hasPublicationYear "2002" @default.
• W2057360087 type Work @default.
• W2057360087 sameAs 2057360087 @default.
• W2057360087 citedByCount "20" @default.
• W2057360087 countsByYear W20573600872013 @default.
• W2057360087 countsByYear W20573600872015 @default.
• W2057360087 countsByYear W20573600872016 @default.
• W2057360087 countsByYear W20573600872019 @default.
• W2057360087 countsByYear W20573600872021 @default.
• W2057360087 countsByYear W20573600872022 @default.
• W2057360087 crossrefType "journal-article" @default.
• W2057360087 hasAuthorship W2057360087A5002556868 @default.
• W2057360087 hasAuthorship W2057360087A5030969362 @default.
• W2057360087 hasAuthorship W2057360087A5032646223 @default.
• W2057360087 hasAuthorship W2057360087A5078086617 @default.
• W2057360087 hasConcept C10205521 @default.
• W2057360087 hasConcept C109159458 @default.
• W2057360087 hasConcept C121608353 @default.
• W2057360087 hasConcept C126322002 @default.
• W2057360087 hasConcept C142724271 @default.
• W2057360087 hasConcept C150903083 @default.
• W2057360087 hasConcept C201750760 @default.
• W2057360087 hasConcept C203014093 @default.
• W2057360087 hasConcept C207001950 @default.
• W2057360087 hasConcept C26291073 @default.
• W2057360087 hasConcept C2775930923 @default.
• W2057360087 hasConcept C2780007613 @default.
• W2057360087 hasConcept C28328180 @default.
• W2057360087 hasConcept C502942594 @default.
• W2057360087 hasConcept C530470458 @default.
• W2057360087 hasConcept C54355233 @default.
• W2057360087 hasConcept C55427017 @default.
• W2057360087 hasConcept C71924100 @default.
• W2057360087 hasConcept C86803240 @default.
• W2057360087 hasConceptScore W2057360087C10205521 @default.
• W2057360087 hasConceptScore W2057360087C109159458 @default.
• W2057360087 hasConceptScore W2057360087C121608353 @default.
• W2057360087 hasConceptScore W2057360087C126322002 @default.
• W2057360087 hasConceptScore W2057360087C142724271 @default.
• W2057360087 hasConceptScore W2057360087C150903083 @default.
• W2057360087 hasConceptScore W2057360087C201750760 @default.
• W2057360087 hasConceptScore W2057360087C203014093 @default.
• W2057360087 hasConceptScore W2057360087C207001950 @default.
• W2057360087 hasConceptScore W2057360087C26291073 @default.
• W2057360087 hasConceptScore W2057360087C2775930923 @default.
• W2057360087 hasConceptScore W2057360087C2780007613 @default.
• W2057360087 hasConceptScore W2057360087C28328180 @default.
• W2057360087 hasConceptScore W2057360087C502942594 @default.
• W2057360087 hasConceptScore W2057360087C530470458 @default.
• W2057360087 hasConceptScore W2057360087C54355233 @default.
• W2057360087 hasConceptScore W2057360087C55427017 @default.
• W2057360087 hasConceptScore W2057360087C71924100 @default.
• W2057360087 hasConceptScore W2057360087C86803240 @default.
• W2057360087 hasIssue "2-3" @default.
• W2057360087 hasLocation W20573600871 @default.

• next